TOI
Oncology Institute Inc
6.20$
+20.9%
vs. previous close
Closing price · As of: Aug 11, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | +411.1% | -219.2% | – | – | – | -168.5% | – | |
| – | +27.8% | -7.1% | -5.6% | +1.9% | +3.6% | +8.5% | +4.5% | +1.2% | -4.5% | -210.0% | – | – | |
| – | +13.4% | -12.4% | +0.2% | -17.1% | -29.5% | -46.0% | +13.1% | -48.4% | +36.2% | -187.2% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -161.7% | – | -142.4% | – | – | +11.1% | -75.4% | -205.0% | – | – | -87.9% | – | |
| – | -0.7% | -7.4% | -29.2% | +199.3% | -78.0% | +336.6% | -81.3% | +268.3% | -50.0% | +75.5% | -1.7% | – | |
| – | -69.0% | +50.8% | +66.7% | -6.3% | -42.8% | -116.9% | -88.5% | +498.0% | -50.0% | +75.5% | -1.7% | – | |
| – | – | +0.0% | +0.0% | – | – | – | – | – | – | – | – | – | |
| – | -86.0% | -100.0% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | -9.1% | +200,000.0% | -100.0% | -20.0% | +12.5% | +0.0% | – | |
| – | -70.9% | +135.6% | -47.3% | +128.9% | -88.7% | -32.5% | +2,790.2% | – | +440.0% | -64.8% | -100.7% | – | |
| – | -109.9% | – | -56.9% | -85.6% | +2,875.1% | -79.3% | -538.0% | – | – | – | -155.6% | – | |
| – | – | – | – | – | – | +99.1% | -318.7% | – | – | – | -249.9% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 11, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.